Kiniksa Pharmaceuticals, Ltd.
KNSA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $18 | $18 | $9 | -$9 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $4 | $3 | $3 | -$3 |
| Stock-Based Comp. | $10 | $9 | $8 | $8 |
| Change in WC | -$1 | -$2 | $2 | $21 |
| Other Non-Cash | $2 | $0 | $1 | $2 |
| Operating Cash Flow | $34 | $28 | $22 | $19 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$146 | -$34 | -$95 | -$22 |
| Inv. Sales/Matur. | $84 | $31 | $44 | $87 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$63 | -$4 | -$52 | $65 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$4 | -$2 | -$0 | -$1 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $16 | $13 | $3 | $3 |
| Financing Cash Flow | $12 | $11 | $3 | $2 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$17 | $35 | -$26 | $86 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $192 | $157 | $184 | $97 |
| End Cash | $175 | $192 | $157 | $184 |
| Free Cash Flow | $33 | $28 | $22 | $19 |